An unexpected discovery led to the question: why game-changing cancer immunotherapy treatments work for only a fraction of patients? The answer: stanniocalcin-1, a glycoprotein.
Engineers and oncologists teamed to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes.
A new understanding of intracellular pathways activated as T cells start to mount an immune response offers clues against graft-versus-host disease, a serious complication of bone marrow transplantation.
Homing in on about 20 key genes known to be associated with breast or ovarian cancer is likely to provide patients and their doctors with “news they can use," according to a new study.
A coalition of 76 organizations has released an open letter reminding the public that cancer still poses a major threat to people’s health, but acting as soon as is safely possible can lead to much better outcomes
in the future.
The University of Michigan ranks No. 9 among institutions globally in cancer research according to the U.S. News & World Report 2021 Best Global University Rankings.
MENU
